Results 191 to 200 of about 93,963 (358)

Identification of New KCNT1‐Epilepsy Drugs by In Silico, Cell, and Drosophila Modeling

open access: yesAnnals of Neurology, Volume 98, Issue 6, Page 1261-1274, December 2025.
Objective Hyperactive KCNT1 potassium channels, caused by gain‐of‐function mutations, are associated with a range of epilepsy disorders. Patients typically experience drug‐resistant seizures and, in cases with infantile onset, developmental regression can follow.
Michael G. Ricos   +9 more
wiley   +1 more source

Mitochondrial HMG‐CoA Synthase Deficiency Presenting as Pediatric Metabolic Stroke: A Case Report of a Novel Homozygous HMGCS2 (p.Ile56Asn) Variant

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Mitochondrial HMG‐CoA synthase deficiency should be suspected in infants with hypoketotic hypoglycemia, metabolic acidosis, and basal ganglia lesions. A 2‐year‐old boy with a novel HMGCS2 variant presented with refractory seizures and encephalopathy, highlighting the need for rapid metabolic and genetic evaluation for timely management.
Yasmeen Alshami   +7 more
wiley   +1 more source

Effects of Phenytoin on the Retinal Ganglion Cell-Inner Plexiform Layer in Acute Optic Neuritis: Analysis of a Phase II Randomized Trial. [PDF]

open access: yesNeurology
Kodali S   +13 more
europepmc   +1 more source

Advancing Predictions of Oral Drug Absorption, CYP3A4 Induction, and Transporter‐Mediated Interactions Using a Human Primary Intestinal 3D Model (EpiIntestinal™)

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1499-1511, December 2025.
Accurate prediction of oral drug absorption in humans is essential for early drug development; however, physiologically relevant human models are lacking. This study aims to comprehensively assess the EpiIntestinal™, a human primary intestinal 3D model, for its ability to predict oral absorption (Fa), intestinal availability (Fg), CYP3A4 induction, and
Paresh P. Chothe   +4 more
wiley   +1 more source

Particle size distribution affects the human bioavailability of phenytoin.

open access: bronze, 1986
SHIGERU YAKOU   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy